4-(2-phenyl-1-ethyl)-1-(3-trifluoromethylphenyl)piperazine | 147429-40-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 4-(2-phenyl-1-ethyl)-1-(3-trifluoromethylphenyl)piperazine
• 英文别名: 1-(3-Trifloromethylphenyl)-4-(2-phenyl-1-ethyl)piperazine；1-(2-phenylethyl)-4-[3-(trifluormethyl)phenyl]piperazine；1-phenethyl-4-(3-trifluoromethyl-phenyl)-piperazine；1-Phenethyl-4-[3-(trifluoromethyl)phenyl]piperazine；1-(2-phenylethyl)-4-[3-(trifluoromethyl)phenyl]piperazine
• CAS: 147429-40-1
• 化学式: C₁₉H₂₁F₃N₂
• 分子量: 334.384
• InChiKey: SQJJIPWVYJPFNA-UHFFFAOYSA-N

物化性质

• 沸点：
  414.0±45.0 °C(Predicted)
• 密度：
  1.175±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  6.5
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  2-phenyl-1-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethan-1-one 在 dimethyl sulfide borane 作用下， 以 四氢呋喃 为溶剂， 反应 48.0h， 生成 4-(2-phenyl-1-ethyl)-1-(3-trifluoromethylphenyl)piperazine
  参考文献：
  名称：

  Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as high-affinity .sigma. ligands

  摘要：

  Sigma-receptors may represent an exciting new approach for the development of novel psychotherapeutic agents. Unfortunately, many of the commonly used sigma-ligands lack selectivity (e.g., many bind at phencyclidine or dopamine receptors) or suffer from other serious drawbacks. Recently, we described a series of 2-phenylaminoethanes that bind at sigma-receptors with high affinity and selectivity. Because there is evidence that 1-phenylpiperazines can structurally mimic the 2-phenylaminoethane moiety, we prepared a series of 1-phenylpiperazines and related analogues and incorporated structural features already shown to enhance the sigma-binding of the 2-phenylaminoethanes. Several of these derivatives bind at sigma-receptors with high affinity (K(i) = 1-10 nM) and lack appreciable affinity for phencyclidine and dopamine receptors. In as much as certain of these agents structurally resemble the high-affinity, but nonselective, sigma-ligand haloperidol, and because they bind with 10 times the affinity of haloperidol, we have apparently identified what appears to be the primary sigma-pharmacophore of that agent.

  DOI：

  10.1021/jm00116a003

文献信息

• Base-catalyzed hydroamination of aromatic olefins-an efficient route to 1-aryl-4-(arylethyl)piperazines
  作者：Matthias Beller、Claudia Breindl

  DOI：10.1016/s0040-4020(98)00295-6

  日期：1998.6

  An efficient synthesis of pharmaceutically interesting 1-aryl-4-(arylethyl)piperazines by base-catalyzed hydroamination is presented. Starting from substituted aryl olefins and various N-arylpiperazines, the desired products 3 – 12 were obtained in one step under mild conditions in the presence of a catalytic amount of n-butyllithium in yields up to 99%.

  提出了一种通过碱催化的加氢胺化反应来有效合成可药用的1-芳基-4-（芳基乙基）哌嗪的方法。从取代的芳基烯烃和各种起始Ñ -arylpiperazines，所需产物12 - 3在催化量的存在下在温和条件下一个步骤获得Ñ丁基锂在产率高达99％。
• Modulators of dopamine neurotransmission
  申请人：Sonesson Clas

  公开号：US20060135531A1

  公开（公告）日：2006-06-22

  A 3-substituted 4-(phenyl-N-alkyl)-piperazine compound of the following formula: wherein R 1 is selected from the group consisting of OSO 2 CF 3 , OSO 2 CH 3 , SO 2 R 3 , COCF 3 , COCH 3 and COCH 2 CH 3 , wherein R 3 is as defined hereafter; R 2 is selected from the group consisting of C 1 -C 4 alkyls, allyl, CH 2 CH 2 CH 2 F, CH 2 CF 3 , 3,3,3-trifluoropropyl and 4,4,4-trifluorobutyl; R 3 is selected from the group consisting of C 1 -C 3 alkyls, CF 3 , and N(CH 3 ) 2 ; with the proviso that when R 1 is SO 2 R 3 and R 3 is a C 1 -C 3 alkyl, then R 2 is not CH 2 CH 2 OCH 3 ; or a pharmaceutically acceptable salt thereof are provided. Also, pharmaceutical compositions comprising the above compound and methods wherein the above compound is used for the treatment of various disorders are provided.

  提供以下结构的3-取代的4-(苯基-N-烷基)-哌嗪化合物：其中R1从OSO2CF3、OSO2CH3、SO2R3、COCF3、COCH3和COCH2CH3组成的群体中选择，其中R3如下所定义；R2从C1-C4烷基、烯丙基、CH2CH2CH2F、CH2CF3、3,3,3-三氟丙基和4,4,4-三氟丁基组成的群体中选择；R3从C1-C3烷基、CF3和N(CH3)2组成的群体中选择；但有一个条件，即当R1为SO2R3且R3为C1-C3烷基时，R2不是CH2CH2OCH3；或者其药学上可接受的盐。此外，还提供包含上述化合物的药物组合物和使用上述化合物治疗各种疾病的方法。
• [EN] NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION<br/>[FR] NOUVEAUX MODULATEURS DE NEUROTRANSMISSION PAR DOPAMINE
  申请人：CARLSSON A RESEARCH AB

  公开号：WO2001046145A1

  公开（公告）日：2001-06-28

  New 3-substituted 4-(phenyl-N-alkyl)-piperazine and 4-(phenyl-N-alkyl)-piperidine compounds of Formula (1), wherein X N, CH, or C, however X may only be C when the compound comprises a double bond at the dotted line; R1 is OSO2CF3, OSO2CH3, SOR3, SO2R3, COR3, NO2, or CONHR3 and when X is CH or C R1 may also be CF3, CN, F, C1, Br, or I; R2 is a C1-C4 alkyl, an allyl, CH2SCH3, CH2CH2OCH3, CH2CH2CH2F, CH2CF3, 3,3,3-trifluoropropyl, 4,4,4- trifluorobutyl, or - (CH2) - R4; R3 is a C1-C3 alkyl, CF3, or N(R2)2; R4 is a C3-C6 cycloalkyl, 2-tetrahydrofurane or 3-tetra-hydrofurane, as well as pharmaceutically acceptable salts thereof are disclosed. Also pharmaceutical compositions comprising the above compounds and methods wherein the above compounds are used for treatment of disorders in the central nervous system are disclosed.

  公开了式（1）的新3-取代4-(苯基-N-烷基)-哌嗪和4-(苯基-N-烷基)-哌啶化合物，其中X为N、CH或C，但当该化合物在虚线处具有双键时，X只能为C；R1为OSO2CF3、OSO2CH3、SOR3、SO2R3、COR3、NO2或CONHR3，当X为CH或C时，R1还可以是CF3、CN、F、C1、Br或I；R2为C1-C4烷基、烯丙基、CH2SCH3、CH2CH2OCH3、CH2CH2CH2F、CH2CF3、3,3,3-三氟丙基、4,4,4-三氟丁基或-(CH2)-R4；R3为C1-C3烷基、CF3或N(R2)2；R4为C3-C6环烷基、2-四氢呋喃或3-四氢呋喃，以及其药学上可接受的盐。还公开了包括上述化合物的制药组合物以及使用上述化合物治疗中枢神经系统疾病的方法。
• The First Rhodium-Catalyzed Anti-Markovnikov Hydroamination: Studies on Hydroamination and Oxidative Amination of Aromatic Olefins
  作者：M. Beller、H. Trauthwein、M. Eichberger、C. Breindl、J. Herwig、T. E. Müller、O. R. Thiel

  DOI：10.1002/(sici)1521-3765(19990401)5:4<1306::aid-chem1306>3.0.co;2-4

  日期：1999.4.1

  The first transition-metal-catalyzed regiospecific anti-Markovnikov hydroamination of aromatic olefins is reported. Styrene and substituted styrenes react with secondary aliphatic amines, especially morpholine and N-arylpiperazines, in the presence of cationic rhodium complexes to give 2-aminoethenylbenzene and 2-aminoethylbenzene derivatives. Cationic [Rh(cod)(2)]+BF4- and various phosphines (1:2-mixture) were employed as in situ catalysts. According to labeling experiments, there is no evidence that the hydroamination is a consecutive hydrogenation of a previously formed enamine. Hydroamination with simple secondary amines, for example piperidine, can also be achieved by the use of a higher olefin concentration and higher reaction temperatures than those given in previously published reaction procedures. Kinetic investigations of the major reaction pathway reveal that the reaction rate of the oxidative amination and the hydroamination is dependent on the styrene and on the catalyst concentration, and independent of the amine concentration. Experiments that employed deuterium-labeled amines (N-D) provided evidence that the mechanism involves an amine-activating pathway, The substituents on the styrene, the phosphine ligand, and the solvent influence the yield of the aminations and the enamine:alkylamine ratio.
• SIGMA RECEPTOR LIGANDS AND THE USE THEREOF
  申请人：VIRGINIA COMMONWEALTH UNIVERSITY

  公开号：EP0591426A1

  公开（公告）日：1994-04-13